Correlation Between Edgewise Therapeutics and Revolution Medicines
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Revolution Medicines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Revolution Medicines into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and Revolution Medicines, you can compare the effects of market volatilities on Edgewise Therapeutics and Revolution Medicines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Revolution Medicines. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Revolution Medicines.
Diversification Opportunities for Edgewise Therapeutics and Revolution Medicines
0.79 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Edgewise and Revolution is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Revolution Medicines in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Revolution Medicines and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Revolution Medicines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Revolution Medicines has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Revolution Medicines go up and down completely randomly.
Pair Corralation between Edgewise Therapeutics and Revolution Medicines
Given the investment horizon of 90 days Edgewise Therapeutics is expected to generate 1.49 times more return on investment than Revolution Medicines. However, Edgewise Therapeutics is 1.49 times more volatile than Revolution Medicines. It trades about 0.07 of its potential returns per unit of risk. Revolution Medicines is currently generating about -0.03 per unit of risk. If you would invest 2,703 in Edgewise Therapeutics on November 2, 2024 and sell it today you would earn a total of 97.00 from holding Edgewise Therapeutics or generate 3.59% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Edgewise Therapeutics vs. Revolution Medicines
Performance |
| Timeline |
| Edgewise Therapeutics |
| Revolution Medicines |
Edgewise Therapeutics and Revolution Medicines Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Edgewise Therapeutics and Revolution Medicines
The main advantage of trading using opposite Edgewise Therapeutics and Revolution Medicines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Revolution Medicines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Revolution Medicines will offset losses from the drop in Revolution Medicines' long position.| Edgewise Therapeutics vs. Surrozen | Edgewise Therapeutics vs. Armata Pharmaceuticals | Edgewise Therapeutics vs. Pasithea Therapeutics Corp | Edgewise Therapeutics vs. Aditxt Inc |
| Revolution Medicines vs. Blueprint Medicines Corp | Revolution Medicines vs. Sana Biotechnology | Revolution Medicines vs. Kymera Therapeutics | Revolution Medicines vs. Monte Rosa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |